Search Ontology:
ChEBI
(3R,4R,5S)-5-[(1R)-2-[(2R,3R,4R,5S)-5-[(1R)-1,2-Dihydroxyethyl]-4-[(2S,3R,4R,5S)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy-3-hydroxyoxolan-2-yl]oxy-1-hydroxyethyl]oxolane-2,3,4-triol
- Term ID
- CHEBI:155782
- Synonyms
-
- beta-D-galacto-hexofuranosyl-(1->3)-beta-D-galacto-hexofuranosyl-(1->6)-D-galacto-hexofuranose
- Galf(b1-3)Galf(b1-6)Galf
- WURCS=2.0/2,3,2/[a2112h-1x_1-4][a2112h-1b_1-4]/1-2-2/a6-b1_b3-c1
- Definition
- References
-
- GlyGen:G99807HK
- GlyTouCan:G99807HK
- Ontology
- ChEBI ( EBI )
- is a type of
-
Phenotype
Phenotype resulting from (3R,4R,5S)-5-[(1R)-2-[(2R,3R,4R,5S)-5-[(1R)-1,2-Dihydroxyethyl]-4-[(2S,3R,4R,5S)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy-3-hydroxyoxolan-2-yl]oxy-1-hydroxyethyl]oxolane-2,3,4-triol
Phenotype where environments contain (3R,4R,5S)-5-[(1R)-2-[(2R,3R,4R,5S)-5-[(1R)-1,2-Dihydroxyethyl]-4-[(2S,3R,4R,5S)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy-3-hydroxyoxolan-2-yl]oxy-1-hydroxyethyl]oxolane-2,3,4-triol
Phenotype modified by environments containing (3R,4R,5S)-5-[(1R)-2-[(2R,3R,4R,5S)-5-[(1R)-1,2-Dihydroxyethyl]-4-[(2S,3R,4R,5S)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy-3-hydroxyoxolan-2-yl]oxy-1-hydroxyethyl]oxolane-2,3,4-triol
Human Disease Model